POPULARITY
Categories
116 episodes with Cleveland Clinic
55 episodes with Cleveland Clinic
54 episodes with Cleveland Clinic
74 episodes with Cleveland Clinic
22 episodes with Cleveland Clinic
49 episodes with Cleveland Clinic
74 episodes with Cleveland Clinic
56 episodes with Cleveland Clinic
68 episodes with Cleveland Clinic
32 episodes with Cleveland Clinic
30 episodes with Cleveland Clinic
35 episodes with Cleveland Clinic
19 episodes with Cleveland Clinic
34 episodes with Cleveland Clinic
65 episodes with Cleveland Clinic
30 episodes with Cleveland Clinic
23 episodes with Cleveland Clinic
17 episodes with Cleveland Clinic
12 episodes with Cleveland Clinic
13 episodes with Cleveland Clinic
13 episodes with Cleveland Clinic
21 episodes with Cleveland Clinic
17 episodes with Cleveland Clinic
11 episodes with Cleveland Clinic
10 episodes with Cleveland Clinic
14 episodes with Cleveland Clinic
12 episodes with Cleveland Clinic
14 episodes with Cleveland Clinic
17 episodes with Cleveland Clinic
11 episodes with Cleveland Clinic
14 episodes with Cleveland Clinic
17 episodes with Cleveland Clinic
11 episodes with Cleveland Clinic
11 episodes with Cleveland Clinic
9 episodes with Cleveland Clinic
10 episodes with Cleveland Clinic
9 episodes with Cleveland Clinic
7 episodes with Cleveland Clinic
9 episodes with Cleveland Clinic
10 episodes with Cleveland Clinic
10 episodes with Cleveland Clinic
12 episodes with Cleveland Clinic
7 episodes with Cleveland Clinic
9 episodes with Cleveland Clinic
8 episodes with Cleveland Clinic
8 episodes with Cleveland Clinic
7 episodes with Cleveland Clinic
8 episodes with Cleveland Clinic
9 episodes with Cleveland Clinic
6 episodes with Cleveland Clinic
12 episodes with Cleveland Clinic
7 episodes with Cleveland Clinic
16 episodes with Cleveland Clinic
5 episodes with Cleveland Clinic
4 episodes with Cleveland Clinic
13 episodes with Cleveland Clinic
9 episodes with Cleveland Clinic
12 episodes with Cleveland Clinic
7 episodes with Cleveland Clinic
6 episodes with Cleveland Clinic
6 episodes with Cleveland Clinic
7 episodes with Cleveland Clinic
8 episodes with Cleveland Clinic
9 episodes with Cleveland Clinic
5 episodes with Cleveland Clinic
20 episodes with Cleveland Clinic
7 episodes with Cleveland Clinic
5 episodes with Cleveland Clinic
6 episodes with Cleveland Clinic
4 episodes with Cleveland Clinic
5 episodes with Cleveland Clinic
6 episodes with Cleveland Clinic
10 episodes with Cleveland Clinic
7 episodes with Cleveland Clinic
3 episodes with Cleveland Clinic
11 episodes with Cleveland Clinic
4 episodes with Cleveland Clinic
12 episodes with Cleveland Clinic
5 episodes with Cleveland Clinic
108 episodes with Cleveland Clinic
5 episodes with Cleveland Clinic
5 episodes with Cleveland Clinic
10 episodes with Cleveland Clinic
6 episodes with Cleveland Clinic
5 episodes with Cleveland Clinic
5 episodes with Cleveland Clinic
5 episodes with Cleveland Clinic
5 episodes with Cleveland Clinic
3 episodes with Cleveland Clinic
3 episodes with Cleveland Clinic
7 episodes with Cleveland Clinic
10 episodes with Cleveland Clinic
5 episodes with Cleveland Clinic
4 episodes with Cleveland Clinic
3 episodes with Cleveland Clinic
4 episodes with Cleveland Clinic
3 episodes with Cleveland Clinic
4 episodes with Cleveland Clinic
6 episodes with Cleveland Clinic
16 episodes with Cleveland Clinic
4 episodes with Cleveland Clinic
5 episodes with Cleveland Clinic
11 episodes with Cleveland Clinic
2 episodes with Cleveland Clinic
12 episodes with Cleveland Clinic
4 episodes with Cleveland Clinic
7 episodes with Cleveland Clinic
5 episodes with Cleveland Clinic
8 episodes with Cleveland Clinic
6 episodes with Cleveland Clinic
7 episodes with Cleveland Clinic
5 episodes with Cleveland Clinic
11 episodes with Cleveland Clinic
4 episodes with Cleveland Clinic
4 episodes with Cleveland Clinic
6 episodes with Cleveland Clinic
2 episodes with Cleveland Clinic
3 episodes with Cleveland Clinic
3 episodes with Cleveland Clinic
4 episodes with Cleveland Clinic
6 episodes with Cleveland Clinic
5 episodes with Cleveland Clinic
5 episodes with Cleveland Clinic
5 episodes with Cleveland Clinic
4 episodes with Cleveland Clinic
5 episodes with Cleveland Clinic
3 episodes with Cleveland Clinic
4 episodes with Cleveland Clinic
5 episodes with Cleveland Clinic
4 episodes with Cleveland Clinic
14 episodes with Cleveland Clinic
3 episodes with Cleveland Clinic
5 episodes with Cleveland Clinic
4 episodes with Cleveland Clinic
3 episodes with Cleveland Clinic
In this episode of AUA Inside Tract, join Dr. Petar Bajic, director of Men's Health, and Dr. Raevti Bole, Men's Health specialist, from the Cleveland Clinic as they share clinical insights and real-world perspectives on men's health. From prevention to patient care, this episode highlights what clinicians need to know during Men's Health Month.
Have a question? Click here. In this toxic fish tale episode, I share my personal experience with ciguatera poisoning - a rare form of food poisoning that landed me on the bathroom floor of a Bahamas resort and changed how I think about seafood forever. While this isn't our typical "age with grace and strength" content, it's an important story about advocacy, awareness, and making informed choices about the fish we eat.What HappenedDuring a 2019 family vacation in the Bahamas, I ordered the "fish of the day" at a resort steakhouse while my family had steak. That night, I became violently ill with what would later be diagnosed as ciguatera poisoning - a rare condition listed on rarediseases.org.Key Points Discussed:What is Ciguatera Poisoning?High-Risk Fish SpeciesHigh-Risk RegionsMy Symptoms Recovery Protocol Links Mentioned:Ciguatera Poisoning: How I Manage my Symptoms with Food, Supplements, and Exercise (YouTube)Ciguatera Experience: Updates and Encouragement After Six Years (YouTube)Article from Cleveland Clinic about ciguateraMonterey Bay Aquarium Seafood Watch GuideJoin The Stronger Collective Nourished Notes Bi-Weekly Newsletter 30+ Non-Gym Ways to Improve Your Health (free download)Connect with Amy: GracedHealth.com Instagram: @GracedHealthYouTube: @AmyConnell
About the Speakers:Dr. Thureiyya K. Rodriguez, DHA, MSN, CWOCN, has over two decades of experience in healthcare and specializes in wound, ostomy, and continence nursing. Dr. Rodriguez's experience spans beyond inpatient and outpatient nursing. She has an extensive range of knowledge and expertise in staffing methodology and leadership nursing. Dr. Rodriguez's experience in nursing practice and healthcare administration, combined with her tenure in both federal and private healthcare sectors, equips her to offer comprehensive and tailored solutions. Dr. Rodriguez has peer-reviewed publications in Nursing Made Incredibly Easy and is an active peer reviewer for Wolters-Kluwer: Advances in Skin and Wound Care. She is actively involved in the Northeast Region WOCN (NER WOCN) and National Society of Leadership and Success (NSLS). She is the owner of Thureiyya Rodriguez RN, PLLC and North-Browne Consulting Services.Katie Cesario, MA, RN, CWOCN, became a nurse in 2005 after obtaining her BSN from Pace University. She started her career at Visiting Nurse Service of New York as a public health nurse intern. In 2009, she received her Master's Degree in Nursing Education from Pace University and soon after took a position as Orientation Nurse Instructor at VNSNY. In 2013, she studied at the Cleveland Clinic to become a Wound, Ostomy, Continence Nurse. In 2015, she took a WOC nurse position at New York Presbyterian, Columbia University Medical Center. In September 2018, she joined the WOC nurse team at NYP, Brooklyn Methodist Hospital. She held the Secretary position for the Metro NY Affiliate of the WOCN Society from January 2021-December 2022. Since 2019, she has served on the skin and wound care advisory board for Coloplast. Presently, she is embarking on a new path in her career by starting her own private nursing business for wound and ostomy patients and their caregivers, Katherine Cesario RN, PLLC. In this new role, she is most excited to combine her background in home care and education with her dedication to help people living with wounds and ostomies.Editing and post-production work for this episode was provided by The Podcast Consultant.
Hello, and welcome to episode 175 of the Childless Not by Choice Podcast. My name is Civilla Morgan. My mission is to recognize and speak to childless women and men not by choice worldwide, reminding us that we can live joyful, relevant, and fulfilled lives, childless by choice. Whether you have children or not, thank you for tuning in! What is today's show about? Father's Day and Men's Health Thank you, Patreon contributors: I would like to thank my Patreon contributors, who support the platform every month. Your contributions help me pay my podcast producer, my podcast host, Zoom, where I interview most of my guests, and other expenses. Thank you very much! If you are not yet a Patron, visit patreon.com/childlessnotbychoice to set up your monthly contribution. No matter your giving level, I have a gift for you! If you prefer to give via PayPal, you can find me there at booksbycivillamorgan@gmail.com. Your contributions to the platform are greatly appreciated! Thank you! https://www.patreon.com/Childlessnotbychoice Questions or comments? Contact me at: Email: Info@civillamorgan.com Or Visit the website at www.childlessnotbychoice.net, look to the left on the home screen, and click on the link below the telephone to leave me an up to 90-second voicemail. Body of episode: FATHER'S DAY MEN'S HEALTH So, well before President Biden's prostate cancer diagnosis, I had planned on discussing men's health for this year's Father's Day episode. In particular, I wanted to discuss causes of male childlessness, such as Azoospermia. I've decided to put links in the show notes in regards to Azoospermia. Please check out the links for further information. The basic definition of Azoospermia per The Cleveland Clinic website is: ‘Azoospermia means there's no sperm in your ejaculate. Its causes include a blockage along the reproductive tract, hormonal problems, ejaculation problems or issues with testicular structure or function. Many causes are treatable. For other causes, it may be possible to retrieve live sperm to be used in assisted reproductive techniques like IVF.‘ As I think back through my episodes, I don't believe I've ever discussed men's health, or medical reasons men may be childless. We've discussed fibroids, PCOS, endometriosis, adenomyosis, miscarriage, running out of time, aka the biological clock, MRKH, etc. But I've never gone into much detail regarding issues surrounding the causes of childlessness in men. I have had the great opportunity to interview several men about their experiences with childlessness, including how they have dealt with it. I will put links in the show notes on interviews I have conducted over the years with these wonderful men. Be sure to take a listen! I also believe male childlessness is not as openly discussed as female childlessness because men and their spouses may find the issue embarrassing, shocking to their ego in a different way than a woman may feel about her childlessness, or maybe in much the same way. In either case, there can be emotional and mental pain. Some of the things that can cause infertility in men include: AI Overview Male infertility can be caused by a variety of factors, including problems with sperm production or quality, hormonal imbalances, genetic disorders, infections, and environmental factors. Additionally, lifestyle choices like smoking, excessive alcohol consumption, and certain drug use can also contribute to infertility. Here's a more detailed look at some of the key causes: 1. Sperm Problems: Low sperm count (oligospermia): A low number of sperm in the ejaculate. Absent sperm (azoospermia): No sperm in the ejaculate. Poor sperm motility: Sperm are unable to swim properly. Abnormal sperm morphology: Sperm are abnormally shaped, making it difficult for them to fertilize an egg. 2. Hormonal Imbalances: Reduced testosterone: Low levels of testosterone can affect sperm production. Hyperprolactinemia: Elevated levels of prolactin can interfere with sperm production. Hormonal disorders affecting the pituitary gland or hypothalamus: These glands regulate hormone production. 3. Genetic Disorders: Klinefelter syndrome: A genetic condition affecting males. Cystic fibrosis: A genetic disorder that can cause blocked reproductive ducts. Myotonic dystrophy: A genetic disorder that can affect sperm production. 4. Infections and Inflammation: Epididymitis: Inflammation of the epididymis, the tube that carries sperm from the testicles. Orchitis: Inflammation of the testicles. STIs: Sexually transmitted infections like gonorrhea or chlamydia can cause inflammation and damage to the reproductive organs. 5. Environmental and Lifestyle Factors: Smoking: Smoking can reduce sperm count and quality. Alcohol consumption: Excessive alcohol use can lower testosterone levels and affect sperm production. Certain drug use: Anabolic steroids and other drugs can negatively impact sperm production. Exposure to toxins or chemicals: Exposure to certain toxins, like pesticides, can affect fertility. Obesity: Being overweight or obese can impact sperm quality. 6. Medical Conditions: Diabetes: Diabetes can affect sperm production and quality. Kidney failure: Kidney failure can also impact sperm production. Cystic fibrosis: A genetic disorder that can cause blocked reproductive ducts. Autoimmune diseases: Some autoimmune diseases can attack sperm. 7. Other Factors: Varicocele: Enlarged veins in the scrotum, which can raise testicular temperature and affect sperm production. Testicular trauma: Injury to the testicles can damage sperm production. Previous cancer treatment: Chemotherapy and radiation therapy can affect sperm production. Undescended testicles: Testicles that don't descend into the scrotum. Blockages or absences of tubes: Blockages in the reproductive tract can prevent sperm from being released. This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more Whether you have children or not, your health is important. Be sure to go to all of your check-ups, especially if there is a family history of health issues. Get checked, don't wait. Be OK with advocating for yourself. The healthcare industry may say no, you are too young for a particular test. But if you want that test, be insistent. Keep in mind that if your insurance does not cover the test because you are not of a certain age or whatever their parameters are, you may have to pay out of pocket. Happy Father's Day to all the wonderful men out there who do the work of raising great people for this world. Happy Father's Day to those of you who did not birth children, but are contributing to a child's life in beautiful and lasting ways. Research links: https://my.clevelandclinic.org/health/diseases/15441-azoospermia Articles/links of interest: https://ifstudies.org/blog/pronatalism-is-not-popular-yet Episode links to conversations with men: https://childlessnotbychoice.net/episode-143-the-things-men-talk-about-my-conversation-with-dr-robin-hadley/ https://childlessnotbychoice.net/episode-116-my-conversation-with-dave-jackson/ https://childlessnotbychoice.net/episode-141-downriver-nomad-my-conversation-with-rob-hutchings/ https://childlessnotbychoice.net/episode-130-about-fathers-day-and-childlessness/ https://childlessnotbychoice.net/episode-57-men-men-men-men-3/ My contact information: Website: www.childlessnotbychoice.net and www.civillamorgan.com Facebook: booksbycivillamorgan Instagram: @joyandrelevance Pinterest: Civilla M. Morgan, MSM LinkedIn: Civilla Morgan, MSM
I am delighted to connect with Dr. Anshul Gupta today! Dr. Gupta is a best-selling author, speaker, researcher, and world expert on Hashimoto's. He educates people worldwide on reversing Hashimoto's disease. He is a Board-Certified Family Medicine Physician who worked at the prestigious Cleveland Clinic alongside Dr. Mark Hyman. In this episode, Dr. Gupta shares his personal story, and we discuss the root of autoimmunity, how Hashimoto's disease causes the slow destruction of the thyroid gland, and the impact of chronic stress, diet, and an imbalanced gut microbiome. We also discuss toxins and infections, labs to watch out for, fasting and thyroid disease, as well as medication options, peptides, and the issues surrounding iodine supplementation. I sincerely hope you enjoy listening to today's conversation with Dr. Gupta as much as I did recording it! IN THIS EPISODE YOU WILL LEARN: How Dr. Gupta's personal health journey sparked his passion for thyroid issues. What is autoimmunity, and what is Hashimoto's? How increasing doses of thyroid medication indicates a deterioration of the thyroid gland Dr. Gupta shares five major root causes of Hashimoto's. Gluten and dairy, and how they impact the thyroid gland Why are heavy metals such a big issue? Impact of exposure to mold and mycotoxins. Epstein-Barr virus and how it interacts with the thyroid to make people more susceptible to Hashimoto's. How does exposure to stress impact thyroid function? Natural ways to detoxify the body Dr. Gupta talks about lab testing for the thyroid and Hashimoto's. Benefits of fasting for mitochondrial health, particularly for people with thyroid issues Different medication options for people with Hashimoto's, including peptides and LDN (low-dose naltrexone) Dr. Gupta shares his thoughts on iodine. Connect with Cynthia Thurlow Follow on X Instagram LinkedIn Check out Cynthia's website Connect with Dr. Anshul Gupta On his website YouTube and other social media (@AnshulGuptaMD)
THE EMBC NETWORK featuring: ihealthradio and worldwide podcasts
Healthy Decisions, Bold Moves: Dr. Linda Henman on Strategy-Driven Leadership Healthy Decisions, Bold Moves: Dr. Linda Henman on Strategy-Driven Leadership In this thought-provoking episode of The Hurricane H Show we welcome Dr. Linda Henman, renowned organizational strategist, C-suite advisor, and author of Healthy Decisions: Critical Thinking Skills for Healthcare Executives. Dr. Henman breaks down why culture alone isn't enough—and how strategy, clarity, and critical thinking must take center stage in high-stakes decision-making. Drawing from real-world examples like Mercy, Cleveland Clinic, and Banner Health, she explains how top-performing healthcare systems succeed by making the right calls, not just the popular ones. We dive into: Why leaders must stop chasing abstract ideals and start thinking analytically How to make hard decisions in mergers, crises, and operational pivots Why many executives fail to assess risks objectively The overlooked power of dispassionate leadership Lessons from POWs (including John McCain) that shape high-resilience decision-making How healthcare leaders can inspire real innovation—without losing control
THE EMBC NETWORK featuring: ihealthradio and worldwide podcasts
Healthy Decisions, Bold Moves: Dr. Linda Henman on Strategy-Driven Leadership Healthy Decisions, Bold Moves: Dr. Linda Henman on Strategy-Driven Leadership In this thought-provoking episode of The Hurricane H Show we welcome Dr. Linda Henman, renowned organizational strategist, C-suite advisor, and author of Healthy Decisions: Critical Thinking Skills for Healthcare Executives. Dr. Henman breaks down why culture alone isn't enough—and how strategy, clarity, and critical thinking must take center stage in high-stakes decision-making. Drawing from real-world examples like Mercy, Cleveland Clinic, and Banner Health, she explains how top-performing healthcare systems succeed by making the right calls, not just the popular ones. We dive into: Why leaders must stop chasing abstract ideals and start thinking analytically How to make hard decisions in mergers, crises, and operational pivots Why many executives fail to assess risks objectively The overlooked power of dispassionate leadership Lessons from POWs (including John McCain) that shape high-resilience decision-making How healthcare leaders can inspire real innovation—without losing control
In this episode of Leaders in Medical Billing, Chanie Gluck speaks with David Strand, CEO of UnisLink and former COO of the Cleveland Clinic and Alina Health. David brings over 30 years of cross-sector healthcare leadership—from payers to providers to startups—and now leads UnisLink, a fast-growing RCM company backed by Riverside Partners. David dives into what it takes to transition an early-stage RCM company into a scalable, process-driven organization. He shares insights on UnisLink's growth strategy, building offshore teams, AI for denial management, creating a consultative client experience, and the long-term vision of delivering value-based results for small and mid-sized practices. Learn more about UnisLink: https://unislink.com/ Sponsored by 4D Global, empowering medical billing companies through offshore staffing and technology.
We welcome singing voice specialist (SVS) Dr. Nick Klein to the podcast, as he discusses the SVS's role in vocal injury recovery. Dr. Klein and Dr. Bryson also emphasize the importance of multidisciplinary collaboration between medical professionals, speech-language pathologists, and voice teachers to ensure optimal outcomes for this unique patient population.
With a number of late-breaking presentations and high-profile phase 2 and 3 trials, the 2025 American Diabetes Association (ADA) Scientific Sessions reflect how rapidly the treatment landscape for obesity and diabetes is evolving. This year's meeting, held June 20–24 in Chicago, will showcase significant updates on combination therapies, once-weekly insulin regimens, and novel mechanisms that may redefine standards of care for both type 1 and type 2 diabetes. Among the highlights: new efficacy and safety data for GLP-1–based therapies, novel amylin analog combinations, and once-monthly treatment options signal a shift toward personalization and convenience in metabolic care. In this special episode of Diabetes Dialogue cohosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and co-director of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, preview the most anticipated data, explore clinical implications, and discuss what may come next in the exciting pipelines for diabetes and obesity. During the meeting, Isaacs will also participate in a debate on over-the-counter continuous glucose Monitoring with David Ahn, MD, of Hoag, on Friday, June 20, and Bellini will chair 2 sessions, “Real-World Automated Insulin Delivery System Results” on June 20, and “Advances and Trends in Diabetes Technology” on June 22.
Amber Spradlin, Aliza Sherman, & Amy Hooper ////// UpdatesPart 1 of 1 www.TrueCrimeGarage.comThis week from the Garage, we are very happy to be bringing to you major updates in three cases that we have covered. 38 year old Amber Spradlin was killed at an after work party sometime in the night of June 18, 2023. True Crime Garage covered this case in July of 2023 with episode #687. Since, arrests have been made and trial dates have been set. In 2013 Cleveland Clinic nurse Aliza Sherman was killed in downtown Cleveland in broad daylight. Back in December of 2017 we covered his “stranger than fiction” true crime story in a four part series. These were episodes #167 to #170. As we predicted Aliza Sherman's divorce attorney Gregory Moore was arrested and charged with her murder. In March of 1992, Amy Hooper was murdered in her Lincoln Village apartment on the westside of Columbus, Ohio. In December of 2025 Bruce Daniels was arrested for this homicide in Washington state. We are keeping a close eye on this one as it inches closer to the murder trial. Original True Crime Garage coverage: Aliza Sherman - December 2017 - Episodes 167 to 170Amy Hooper - April 2019 - Episodes 294 & 295 Amber Spradlin - July 2023 - Episode 687All are available on this feed - listen for FREE Beer of the Week - Mothman Double Imperial New England Style IPA from Ogopogo BrewingGarage Grade - 4 out of 5 bottle caps More True Crime Garage can be found on Patreon and Apple subscriptions with our show - Off The Record. Catch dozens of episodes of Off The Record plus a couple of Bonus episodes and our first 50 when you sign up today. True Crime Garage merchandise is available on our website's store page. Plus get True Crime Garage Pod art that you can post on your socials on our Media page. Follow the show on X and Insta @TrueCrimeGarage / Follow Nic on X @TCGNIC / Follow The Captain on X @TCGCaptain Thanks for listening and thanks for telling a friend. Be good, be kind, and don't litter!
Send us a textOn this episode, my guest is Paul Papoutsakis. Paul is an Athletic Therapist, Acupuncturist, and Strength and Conditioning Coach working out of the Cleveland Clinic in Toronto since 1999.Since 2003, Paul has also served as the therapist with the National Ballet of Canada. He's also been a tour therapist for Stars on Ice and the Club therapist for the Balmy Beach Rugby Club.Paul is married to his wife Evelyn, and he's a father of two teenage girls. This is a great story of a dedicated practitioner who loves helping people and who has remained steadfast to his community and a life of service. EnjoyIf you liked this EP, please take the time to rate and comment, share with a friend, and connect with us on social channels IG @Kingopain, TW @BuiltbyScott, LI+FB Scott Livingston. You can find all things LYM at www.LYMLab.com, download your free Life Lab Starter Kit today and get busy living https://lymlab.com/free-lym-lab-starter/Please take the time to visit and connect with our sponsors, they are an essential part of our success:www.ReconditioningHQ.comwww.FreePainGuide.com
Continuing our series on What You May Have Missed at ATS 2025, host Amy Attaway, MD, MS, of Cleveland Clinic, dives into key topics from the Clinical Year in Review with Sara Auld, MD, MSc, Emory University. Did you miss the ATS 2025 International Conference? Or were you unable to attend some key sessions? Go to conference.thoracic.org/program/conference-highlights/ to purchase your ATS Conference Highlight Package.
Forever Young Radio Show with America's Natural Doctor Podcast
We have a great episode planned and will focus on Men's Health with a highlight on Hormones. Men are just as vulnerable as Women to having hormonal imbalances or even hormonal issues, but it is just not talked about enough. Today we will talk about who, what, when and where.Talking Points:-Why do men need testosterone?Testosterone is a hormone that plays a vital role in men's health. Low or deficient levels are associated with fatigue, weight gain, muscle and bone mass loss, low libido, depression, impotence, poor memory, and other symptoms.There are many reasons why men can have low testosterone.-How common is Low Testosterone?Low or deficient testosterone in males is problematic in America. According to the Cleveland Clinic, low testosterone affects almost 40% of men aged 45 and older! Testosterone deficiency negatively affects a man's quality of life and is a known risk factor for early death. Testosterone levels are at their highest levels by early adulthood and then decrease by 1% to 2% a year beginning in the 40's.-What causes Low Testosterone?I find that testosterone deficiency or sub-optimal testosterone levels are common in both men and women. If your testosterone levels are low, then you may experience:FatigueLow libidoPoor memory and concentrationLoss of muscle massLoss of bone massIncreased body fatPoor exercise recoveryElevated cholesterol levelsDepressionDecreased resistance to stressErectile Dysfunction (men)Increased heart disease risk-Are there certain foods that can raise or lower Testosterone?-Estrogen Dominance in Men-Let's move on and talk about the Prostate. What is Benign prostatic hyperplasia (BPH?-ROOT CAUSES-How Common-Can it lead to Hormone Imbalance?-ED and Low Libido-Bladder and urinary tract issues?-Any Supportive Supplements for Men dealing with lower Testosterone levels?There are not many supplements proven to increase men's testosterone levels. However, a unique extract of the ayurvedic herb known as ashwagandha has been shown in several studies to elevate male testosterone levels.The ashwagandha extract known as KSM-66 was shown in a recent study to significantly increase blood testosterone levels and sexual well-being. The study involved fifty participants with low sexual desire who were given KSM-66 at a dose of 600 mg or placebo daily. Outcomes were measured with a questionnaire and blood testosterone levels at the beginning and end of the 8-week study. Compared to the placebo, the KSM-66 demonstrated significant benefits.The ashwagandha extract in this study is the same one I use in Testosterone Health (which has 675 mg of KSM-66 per serving). This supplemental approach gives men the potential to improve their libido and testosterone levels without prescription testosterone.-Does Saw Palmetto Really Help the Prostate?Learn more about Dr.StenglerLearn more about Emerald Labs and save 20% off with the code: Forever
Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Stefan Holubar, MD, MS When are ostomies necessary in patients with inflammatory bowel disease? Join Dr. Peter Buch and Dr. Stefan Holubar, Director of Research at the IBD Surgery Section at the Cleveland Clinic, as they explore key surgical considerations for both ulcerative colitis and Crohn's disease, including when to consider temporary versus permanent ileostomies, how to manage complications like anastomotic leaks, and what factors influence the decision to delay or avoid ileal pouch creation.
The evidence for climate change is irrefutable. But how does surgical care contribute to global emissions, and is there anything we can do to make surgery more sustainable? Join Jon Williams and our ASGBI partners for the next installment of our BTK/ASGBI collaborative series, where we discuss how to make surgical care greener. Mrs. Cleo Kennington from the UK and Dr. Benjamin Miller from the US are our guest experts, and provide valuable insights into local sustainability efforts you can take home to your hospital, broader concepts of how high-quality care is sustainable, innovations in sustainability, and what the future of sustainable surgery may look like. After listening, you get to decide–Who has more sustainable surgical practices? The UK or US? Mrs. Cleo Kenington is a Consultant Emergency General and Trauma Surgeon at St George's Hospital, London and was the recent ASGBI Sustainability Lead. She is a big advocate for practicing what she preaches, focusing on how we can reduce the environmental impact at all stages, from cycling to work, preventing complications and unnecessary surgeries, to reducing the use of disposable surgical components. Dr. Benjamin Miller is a general and minimally invasive surgeon at the Cleveland Clinic, with a clinical focus on complex abdominal wall reconstruction. After earning his MD from University of Minnesota School of Medicine in 2011, Dr. Miller went to Nashville to complete his general surgery residency at Vanderbilt University Medical Center. Following this, he became a MIS/complex ab wall fellow at Cleveland Clinic, after which he joined as faculty in 2023. In addition to his clinical interests, Dr. Miller has a deep passion for sustainability efforts within surgical practice, carrying on the legacy of established sustainability efforts within surgical care at Cleveland Clinic and training the next generation of sustainable surgeons. If you enjoyed this episode, stay tuned for more upcoming BTK/ASGBI collaborative content. If you have any questions or comments, please feel free to reach out to us at hello@behindtheknife.org. Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more. If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen
In this episode, Duane Mancini sits down with Isaiah Kaiser, Co-Founder and CEO of Auxilium Health, and Elyse Ball, Vice President of Programming at Bounce Innovation Hub. Fresh off Auxilium Health's exciting $1.5M oversubscribed pre-seed round and new office at Cleveland Clinic, Isaiah returns to share their journey since his first appearance in episode 147. Elyse discusses the vital role of Bounce Innovation Hub in supporting startups and how her journalism background aids in her work. Together, they delve into navigating the regional iCorp program and the JumpStart accelerator, offering invaluable advice for raising capital and maneuvering the startup landscape. Tune in to hear their insights and get a glimpse into Auxilium Health's next major milestones.Isaiah Kaiser LinkedInElyse Ball LinkedInDuane Mancini LinkedInAuxilium Health WebsiteBounce Innovation Hub WebsiteProject Medtech WebsiteProject Medtech LinkedIn
Dr. Nathan Pennell and Dr. Cheryl Czerlanis discuss challenges in lung cancer screening and potential solutions to increase screening rates, including the use of AI to enhance risk prediction and screening processes. Transcript Dr. Nate Pennell: Hello, and welcome to By the Book, a monthly podcast series for ASCO Education that features engaging discussions between editors and authors from the ASCO Educational Book. I'm Dr. Nate Pennell, the co-director of the Cleveland Clinic Lung Cancer Program and vice chair of clinical research for the Taussig Cancer Center. I'm also the editor-in-chief for the ASCO Educational Book. Lung cancer is one of the leading causes of cancer-related mortality worldwide, and most cases are diagnosed at advanced stages where curative treatment options are limited. On the opposite end, early-stage lung cancers are very curable. If only we could find more patients at that early stage, an approach that has revolutionized survival for other cancer types such as colorectal and breast cancer. On today's episode, I'm delighted to be joined by Dr. Cheryl Czerlanis, a professor of medicine and thoracic medical oncologist at the University of Wisconsin Carbone Cancer Center, to discuss her article titled, "Broadening the Net: Overcoming Challenges and Embracing Novel Technologies in Lung Cancer Screening." The article was recently published in the ASCO Educational Book and featured in an Education Session at the 2025 ASCO Annual Meeting. Our full disclosures are available in the transcript of this episode. Cheryl, it's great to have you on the podcast today. Thanks for being here. Dr. Cheryl Czerlanis: Thanks, Nate. It's great to be here with you. Dr. Nate Pennell: So, I'd like to just start by asking you a little bit about the importance of lung cancer screening and what evidence is there that lung cancer screening is beneficial. Dr. Cheryl Czerlanis: Thank you. Lung cancer screening is extremely important because we know that lung cancer survival is closely tied to stage at diagnosis. We have made significant progress in the treatment of lung cancer, especially over the past decade, with the introduction of immunotherapies and targeted therapies based on personalized evaluation of genomic alterations. But the reality is that outside of a lung screening program, most patients with lung cancer present with symptoms related to advanced cancer, where our ability to cure the disease is more limited. While lung cancer screening has been studied for years, the National Lung Screening Trial, or the NLST, first reported in 2011 a significant reduction in lung cancer deaths through screening. Annual low-dose CT scans were performed in a high-risk population for lung cancer in comparison to chest X-ray. The study population was comprised of asymptomatic persons aged 55 to 74 with a 30-pack-year history of smoking who were either active smokers or had quit within 15 years. The low-dose CT screening was associated with a 20% relative risk reduction in lung cancer-related mortality. A similar magnitude of benefit was also reported in the NELSON trial, which was a large European randomized trial comparing low-dose CT with a control group receiving no screening. Dr. Nate Pennell: So, this led, of course, to approval from CMS (Centers for Medicare and Medicaid Services) for lung cancer screening in the Medicare population, probably about 10 years ago now, I think. And there are now two major trials showing an unequivocal reduction in lung cancer-related mortality and even evidence that it reduces overall mortality with lung cancer screening. But despite this, lung cancer screening rates are very low in the United States. So, first of all, what's going on? Why are we not seeing the kinds of screening rates that we see with mammography and colonoscopy? And what are the barriers to that here? Dr. Cheryl Czerlanis: That's a great question. Thank you, Nate. In the United States, recruitment for lung cancer screening programs has faced numerous challenges, including those related to socioeconomic, cultural, logistical, and even racial disparities. Our current lung cancer screening guidelines are somewhat imprecise and often fail to address differences that we know exist in sex, smoking history, socioeconomic status, and ethnicity. We also see underrepresentation in certain groups, including African Americans and other minorities, and special populations, including individuals with HIV. And even where lung cancer screening is readily available and we have evidence of its efficacy, uptake can be low due to both provider and patient factors. On the provider side, barriers include having insufficient time in a clinic visit for shared decision-making, fear of missed test results, lack of awareness about current guidelines, concerns about cost, potential harms, and evaluating both true and false-positive test results. And then on the patient side, barriers include concerns about cost, fear of getting a cancer diagnosis, stigma associated with tobacco smoking, and misconceptions about the treatability of lung cancer. Dr. Nate Pennell: I think those last two are really what make lung cancer unique compared to, say, for example, breast cancer, where there really is a public acceptance of the value of mammography and that breast cancer is no one's fault and that it really is embraced as an active way you can take care of yourself by getting your breast cancer screening. Whereas in lung cancer, between the stigma of smoking and the concern that, you know, it's a death sentence, I think we really have some work to be made up, which we'll talk about in a minute about what we can do to help improve this. Now, that's in the U.S. I think things are probably, I would imagine, even worse when we leave the U.S. and look outside, especially at low- and middle-income countries. Dr. Cheryl Czerlanis: Yes, globally, this issue is even more complex than it is in the United States. Widespread implementation of low-dose CT imaging for lung cancer screening is limited by manpower, infrastructure, and economic constraints. Many low- and middle-income countries even lack sufficient CT machines, trained personnel, and specialized facilities for accurate and timely screenings. Even in urban centers with advanced diagnostic facilities, the high screening and follow-up care costs can limit access. Rural populations face additional barriers, such as geographic inaccessibility of urban centers, transportation costs, language barriers, and mistrust of healthcare systems. In addition, healthcare systems in these regions often prioritize infectious diseases and maternal health, leaving limited room for investments in noncommunicable disease prevention like lung cancer screening. Policymakers often struggle to justify allocating resources to lung cancer screening when immediate healthcare needs remain unmet. Urban-rural disparities exacerbate these challenges, with rural regions frequently lacking the infrastructure and resources to sustain screening programs. Dr. Nate Pennell: Well, it's certainly an intimidating problem to try to reduce these disparities, especially between the U.S. and low- and middle-income countries. So, what are some of the potential solutions, both here in the U.S. and internationally, that we can do to try to increase the rates of lung cancer screening? Dr. Cheryl Czerlanis: The good news is that we can take steps to address these challenges, but a multifaceted approach is needed. Public awareness campaigns focused on the benefits of early detection and dispelling myths about lung cancer screening are essential to improving participation rates. Using risk-prediction models to identify high-risk individuals can increase the efficiency of lung cancer screening programs. Automated follow-up reminders and screening navigators can also ensure timely referrals and reduce delays in diagnosis and treatment. Reducing or subsidizing the cost of low-dose CT scans, especially in low- or middle-income countries, can improve accessibility. Deploying mobile CT scanners can expand access to rural and underserved areas. On a global scale, integrating lung cancer screening with existing healthcare programs, such as TB or noncommunicable disease initiatives, can enhance resource utilization and program scalability. Implementing lung cancer screening in resource-limited settings requires strategic investment, capacity building, and policy interventions that prioritize equity. Addressing financial constraints, infrastructure gaps, and sociocultural barriers can help overcome existing challenges. By focusing on cost-effective strategies, public awareness, and risk-based eligibility criteria, global efforts can promote equitable access to lung cancer screening and improve outcomes. Lastly, as part of the medical community, we play an important role in a patient's decision to pursue lung cancer screening. Being up to date with current lung cancer screening recommendations, identifying eligible patients, and encouraging a patient to undergo screening often is the difference-maker. Electronic medical record (EMR) systems and reminders are helpful in this regard, but relationship building and a recommendation from a trusted provider are really essential here. Dr. Nate Pennell: I think that makes a lot of sense. I mean, there are technology improvements. For example, our lung cancer screening program at The Cleveland Clinic, a few years back, we finally started an automated best practice alert in our EMR for patients who met the age and smoking requirements, and it led to a six-fold increase in people referred for screening. But at the same time, there's a difference between just getting this alert and putting in an order for lung cancer screening and actually getting those patients to go and actually do the screening and then follow up on it. And that, of course, requires having that relationship and discussion with the patient so that they trust that you have their best interests. Dr. Cheryl Czerlanis: Exactly. I think that's important. You know, certainly, while technology can aid in bringing patients in, there really is no substitute for trust-building and a personal relationship with a provider. Dr. Nate Pennell: I know that there are probably multiple examples within the U.S. where health systems or programs have put together, I would say, quality improvement projects to try to increase lung cancer screening and working with their community. There's one in particular that you discuss in your paper called the "End Lung Cancer Now" initiative. I wonder if you could take us through that. Dr. Cheryl Czerlanis: Absolutely. "End Lung Cancer Now" is an initiative at the Indiana University Simon Comprehensive Cancer Center that has the vision to end suffering and death from lung cancer in Indiana through education and community empowerment. We discuss this as a paradigm for how community engagement is important in building and scaling a lung cancer screening program. In 2023, the "End Lung Cancer Now" team decided to focus its efforts on scaling and transforming lung cancer screening rates in Indiana. They developed a task force with 26 experts in various fields, including radiology, pulmonary medicine, thoracic surgery, public health, and advocacy groups. The result of this work is an 85-page blueprint with key recommendations that any system and community can use to scale lung cancer screening efforts. After building strong infrastructure for lung cancer screening at Indiana University, they sought to understand what the priorities, resources, and challenges in their communities were. To do this, they forged strong partnerships with both local and national organizations, including the American Lung Association, American Cancer Society, and others. In the first year, they actually tripled the number of screening low-dose CTs performed in their academic center and saw a 40% increase system-wide. One thing that I think is the most striking is that through their community outreach, they learned that most people prefer to get medical care close to home within their own communities. Establishing a way to support the local infrastructure to provide care became far more important than recruiting patients to their larger system. In exciting news, "End Lung Cancer Now" has partnered with the IU Simon Comprehensive Cancer Center and IU Health to launch Indiana's first and only mobile lung screening program in March of 2025. This mobile program travels around the state to counties where the highest incidence of lung cancer exists and there is limited access to screening. The mobile unit parks at trusted sites within communities and works in partnership, not competition, with local health clinics and facilities to screen high-risk populations. Dr. Nate Pennell: I think that sounds like a great idea. Screening is such an important thing that it doesn't necessarily have to be owned by any one particular health system for their patients. I think. And I love the idea of bringing the screening to patients where they are. I can speak to working in a regional healthcare system with a main campus in the downtown that patients absolutely hate having to come here from even 30 or 40 minutes away, and they'd much rather get their care locally. So that makes perfect sense. So, under the current guidelines, there are certainly things that we can do to try to improve capturing the people that meet those. But are those guidelines actually capturing enough patients with lung cancer to make a difference? There certainly are proposals within patient advocacy communities and even other countries where there's a large percentage of non-smokers who perhaps get lung cancer. Can we expand beyond just older, current and heavy smokers to identify at-risk populations who could benefit from screening? Dr. Cheryl Czerlanis: Yes, I think we can, and it's certainly an active area of research interest. We know that tobacco is the leading cause of lung cancer worldwide. However, other risk factors include secondhand smoke, family history, exposure to environmental carcinogens, and pulmonary diseases like COPD and interstitial lung disease. Despite these known associations, the benefit of lung cancer screening is less well elucidated in never-smokers and those at risk of developing lung cancer because of family history or other risk factors. We know that the eligibility criteria associated with our current screening guidelines focus on age and smoking history and may miss more than 50% of lung cancers. Globally, 10% to 25% of lung cancer cases occur in never-smokers. And in certain parts of the world, like you mentioned, Nate, such as East Asia, many lung cancers are diagnosed in never-smokers, especially in women. Risk-prediction models use specific risk factors for lung cancer to enhance individual selection for screening, although they have historically focused on current or former smokers. We know that individuals with family members affected by lung cancer have an increased risk of developing the disease. To this end, several large-scale, single-arm prospective studies in Asia have evaluated broadening screening criteria to never-smokers, with or without additional risk factors. One such study, the Taiwan Lung Cancer Screening in Never-Smoker Trial, was a multicenter prospective cohort study at 17 medical centers in Taiwan. The primary outcome of the TALENT trial was lung cancer detection rate. Eligible patients aged 55 to 75 had either never smoked or had a light and remote smoking history. In addition, inclusion required one or more of the following risk factors: family history of lung cancer, passive smoke exposure, history of TB or COPD, a high cooking index, which is a metric that quantifies exposure to cooking fumes, or a history of cooking without ventilation. Participants underwent low-dose CT screening at baseline, then annually for 2 years, and then every 2 years for up to 6 years. The lung cancer detection rate was 2.6%, which was higher than that reported in the NLST and NELSON trials, and most were stage 0 or I cancers. Subsequently, this led to the Taiwan Early Detection Program for Lung Cancer, a national screening program that was launched in 2022, targeting 2 screening populations: individuals with a heavy history of smoking and individuals with a family history of lung cancer. We really need randomized controlled trials to determine the true rates of overdiagnosis or finding cancers that would not lead to morbidity or mortality in persons who are diagnosed, and to establish whether the high lung detection rates are associated with a decrease in lung cancer-related mortality in these populations. However, the implementation of randomized controlled low-dose CT screening trials in never-smokers has been limited by the need for large sample sizes, lengthy follow-up, and cost. In another group potentially at higher risk for developing lung cancer, the role of lung cancer screening in individuals who harbor germline pathogenic variants associated with lung cancer also needs to be explored further. Dr. Nate Pennell: We had this discussion when the first criteria came out because there have always been risk-based calculators for lung cancer that certainly incorporate smoking but other factors as well and have discussion about whether we should be screening people based on their risk and not just based on discrete criteria such as smoking. But of course, the insurance coverage for screening, you have to fit the actual criteria, which is very constrained by age and smoking history. Do you think in the U.S. there's hope for broadening our screening beyond NLST and NELSON criteria? Dr. Cheryl Czerlanis: I do think at some point there is hope for broadening the criteria beyond smoking history and age, beyond the criteria that we have typically used and that is covered by insurance. I do think it will take some work to perhaps make the prediction models more precise or to really understand who can benefit. We certainly know that there are many patients who develop lung cancer without a history of smoking or without family history, and it would be great if we could diagnose more patients with lung cancer at an earlier stage. I think this will really count on there being some work towards trying to figure out what would be the best population for screening, what risk factors to look for, perhaps using some new technologies that may help us to predict who is at risk for developing lung cancer, and trying to increase the group that we study to try and find these early-stage lung cancers that can be cured. Dr. Nate Pennell: Part of the reason we, of course, try to enrich our population is screening works better when you have a higher pretest probability of actually having cancer. And part of that also is that our technology is not that great. You know, even in high-risk patients who have CT scans that are positive for a screen, we know that the vast majority of those patients with lung nodules actually don't have lung cancer. And so you have to follow them, you have to use various models to see, you know, what the risk, even in the setting of a positive screen, is of having lung cancer. So, why don't we talk about some newer tools that we might use to help improve lung cancer screening? And one of the things that everyone is super excited about, of course, is artificial intelligence. Are there AI technologies that are helping out in early detection in lung cancer screening? Dr. Cheryl Czerlanis: Yes, that's a great question. We know that predicting who's at risk for lung cancer is challenging for the reasons that we talked about, knowing that there are many risk factors beyond smoking and age that are hard to quantify. Artificial intelligence is a tool that can help refine screening criteria and really expand screening access. Machine learning is a form of AI technology that is adept at recognizing patterns in large datasets and then applying the learning to new datasets. Several machine learning models have been developed for risk stratification and early detection of lung cancer on imaging, both with and without blood-based biomarkers. This type of technology is very promising and can serve as a tool that helps to select individuals for screening by predicting who is likely to develop lung cancer in the future. A group at Massachusetts General Hospital, represented in our group for this paper by my co-authors, Drs. Fintelmann and Chang, developed Sybil, which is an open-access 3D convolutional neural network that predicts an individual's future risk of lung cancer based on the analysis of a single low-dose CT without the need for human annotation or other clinical inputs. Sybil and other machine learning models have tremendous potential for precision lung cancer screening, even, and perhaps especially, in settings where expert image interpretation is unavailable. They could support risk-adapted screening schedules, such as varying the frequency and interval of low-dose CT scans according to individual risk and potentially expand lung cancer screening eligibility beyond age and smoking history. Their group predicts that AI tools like Sybil will play a major role in decoding the complex landscape of lung cancer risk factors, enabling us to extend life-saving lung cancer screening to all who are at risk. Dr. Nate Pennell: I think that that would certainly be welcome. And as AI is working its way into pretty much every aspect of life, including medical care, I think it's certainly promising that it can improve on our existing technology. We don't have to spend a lot of time on this because I know it's a little out of scope for what you covered in your paper, but I'm sure our listeners are curious about your thoughts on the use of other types of testing beyond CT screening for detecting lung cancer. I know that there are a number of investigational and even commercially available blood tests, for example, for detection of lung cancer, or even the so-called multi-cancer detection blood tests that are now being offered, although not necessarily being covered by insurance, for multiple types of cancer, but lung cancer being a common cancer is included in that. So, what do you think? Dr. Cheryl Czerlanis: Yes, like you mentioned, there are novel bioassays such as blood-based biomarker testing that evaluate for DNA, RNA, and circulating tumor cells that are both promising and under active investigation for lung cancer and multi-cancer detection. We know that such biomarker assays may be useful in both identifying lung cancers but also in identifying patients with a high-risk result who should undergo lung cancer screening by conventional methods. Dr. Nate Pennell: Anything that will improve on our rate of screening, I think, will be welcome. I think probably in the future, it will be some combination of better risk prediction and better interpretation of screening results, whether those be imaging or some combination of imaging and biomarkers, breath-based, blood-based. There's so much going on that it is pretty exciting, but we're still going to have to overcome the stigma and lack of public support for lung cancer screening if we're going to move the needle. Dr. Cheryl Czerlanis: Yes, I think moving the needle is so important because we know lung cancer is still a very morbid disease, and our ability to cure patients is not where we would like it to be. But I do believe there's hope. There are a lot of motivated individuals and groups who are passionate about lung cancer screening, like myself and my co-authors, and we're just happy to be able to share some ways that we can overcome the challenges and really try and make an impact in the lives of our patients. Dr. Nate Pennell: Well, thank you, Dr. Czerlanis, for joining me on the By the Book Podcast today and for all of your work to advance care for patients with lung cancer. Dr. Cheryl Czerlanis: Thank you, Dr. Pennell. It's such a pleasure to be with you today. Thank you. Dr. Nate Pennell: And thank you to our listeners for joining us today. You'll find a link to Dr. Czerlanis' article in the transcript of this episode. Please join us again next month for By the Book's next episode and more insightful views on topics you'll be hearing at the education sessions from ASCO meetings throughout the year, and our deep dives on approaches that are shaping modern oncology. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Follow today's speakers: Dr. Nathan Pennell @n8pennell @n8pennell.bsky.social Dr. Cheryl Czerlanis Follow ASCO on social media: @ASCO on X (formerly Twitter) ASCO on Bluesky ASCO on Facebook ASCO on LinkedIn Disclosures: Dr. Nate Pennell: Consulting or Advisory Role: AstraZeneca, Lilly, Cota Healthcare, Merck, Bristol-Myers Squibb, Genentech, Amgen, G1 Therapeutics, Pfizer, Boehringer Ingelheim, Viosera, Xencor, Mirati Therapeutics, Janssen Oncology, Sanofi/Regeneron Research Funding (Institution): Genentech, AstraZeneca, Merck, Loxo, Altor BioScience, Spectrum Pharmaceuticals, Bristol-Myers Squibb, Jounce Therapeutics, Mirati Therapeutics, Heat Biologics, WindMIL, Sanofi Dr. Cheryl Czerlanis: Research Funding (Institution): LungLife AI, AstraZeneca, Summit Therapeutics
In this episode, Scott Becker shares nine key healthcare updates, including Advocate Health's $1.5B innovation district, Cleveland Clinic's tech advancements, financial strain across hospitals, and more.
Join Drs. Michael Rosen, Benjamin T. Miller, Sara Maskal, and Ryan Ellis as they review mesh materials used in hernia repair and the general properties surgeons who perform hernia repairs should know. Hosts: - Sara Maskal, MD, Cleveland Clinic - Ryan Ellis, MD, Cleveland Clinic - Benjamin T. Miller, MD, Cleveland Clinic - Michael Rosen, MD, Cleveland Clinic Learning Objectives: - Understand common mesh materials - Review properties of the different mesh materials - Understand how to apply knowledge of the different mesh properties to different patient scenarios References: - Ellis R, Miller BT. Mesh selection in abdominal wall reconstruction: an update on biomaterials. Surgical Clinics. 2023 Oct 1;103(5):1019-28. https://pubmed.ncbi.nlm.nih.gov/37709387/ - Krpata DM, Petro CC, Prabhu AS, Tastaldi L, Zolin S, Fafaj A, Rosenblatt S, Poulose BK, Pierce RA, Warren JA, Carbonell AM. Effect of hernia mesh weights on postoperative patient-related and clinical outcomes after open ventral hernia repair: a randomized clinical trial. JAMA surgery. 2021 Dec 1;156(12):1085-92. https://pubmed.ncbi.nlm.nih.gov/34524395/ - Rosen MJ, Krpata DM, Petro CC, Carbonell A, Warren J, Poulose BK, Costanzo A, Tu C, Blatnik J, Prabhu AS. Biologic vs synthetic mesh for single-stage repair of contaminated ventral hernias: a randomized clinical trial. JAMA surgery. 2022 Apr 1;157(4):293-301. https://pubmed.ncbi.nlm.nih.gov/35044431/ - Maskal S, Miller B, Ellis R, Phillips S, Prabhu A, Beffa L, Krpata D, Rosenblatt S, Rosen M, Petro C. Mediumweight polypropylene mesh fractures after open retromuscular ventral hernia repair: incidence and associated risk factors. Surgical Endoscopy. 2023 Jul;37(7):5438-43. https://pubmed.ncbi.nlm.nih.gov/37038022/ - Harris HW, Primus F, Young C, Carter JT, Lin M, Mukhtar RA, Yeh B, Allen IE, Freise C, Kim E, Sbitany H. Preventing recurrence in clean and contaminated hernias using biologic versus synthetic mesh in ventral hernia repair: the PRICE randomized clinical trial. https://pubmed.ncbi.nlm.nih.gov/33443907/ - Olavarria OA, Bernardi K, Dhanani NH, Lyons NB, Harvin JA, Millas SG, Ko TC, Kao LS, Liang MK. Synthetic versus biologic mesh for complex open ventral hernia repair: a pilot randomized controlled trial. Surgical Infections. 2021 Jun 1;22(5):496-503. https://pubmed.ncbi.nlm.nih.gov/33259771/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more. If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen
Whole damn show crashed at the start which means you got some solo Lunch riffing for a bit. When we get the partystarted though we start discussing Cleveland Clinic forcing people to pay co-pays before service. Box, by being a smart dude and good bro, knows his sister better than people who are in theory closer to her than him. Box is also considering how he will celebrate his birthday with a potential large purchase. With family coming into town Tee had to clean his son's room, something that hasn't been done in forever. Because we are trying to keep it brief this week there's only one AITA before we wrap with our entertainment recs for the week. Hope you enjoyed the show.See You Next Time, Team SKiM Tatum | TAYREL713 | Lunchbox | LISTEN | RSS | Apple Podcast | Spotify | TuneIn | Bluesky | Amazon Music | YouTube | Email | Amazon Wish List | Merch | Patreon PHONE l 216-264-6311 #Cleveland #Ohio #LiveFromThe216 #CreATine #CoolBreeze #EastPointsGreatestHit #Family #Friendship #Reddit #AITA #TheMentalist #AEW #PPV #CaptainAmericaBraveNewWorld #Thunderbolts #Found #CallofDuty #TheLastofUs #HBO #Andor #StarWars #DisneyPlus #BurnNotice #Hulu #Xbox #GamePass#ClairObscurExpedition33Alternative Title – Girl Be So For Real LinksCleveland Clinic Doubles Back on Its Upfront Copay Policy RedditAITA for walking my friends' under-exercised dog more than they usually do – which led to vet costs and now drama?
Nurses Out Loud with Jodi O'Malley MSN, RN – FDA approved Moderna's MNEXSPIKE COVID-19 vaccine without placebo trials, while a Cleveland Clinic study found the flu shot may have increased COVID-19 risk. Bureaucratic secrecy, incomplete safety data, and suppressed dissent highlight failing “gold standard” claims. Nurses are urged to question mandates, defend ethical integrity, and steadfastly expose medical deception...
Nurses Out Loud with Jodi O'Malley MSN, RN – FDA approved Moderna's MNEXSPIKE COVID-19 vaccine without placebo trials, while a Cleveland Clinic study found the flu shot may have increased COVID-19 risk. Bureaucratic secrecy, incomplete safety data, and suppressed dissent highlight failing “gold standard” claims. Nurses are urged to question mandates, defend ethical integrity, and steadfastly expose medical deception...
A jury convicted suspended East Cleveland Mayor Brandon King yesterday. The jury found King guilty on 10 of 12 corruption-related charges including theft in office and having an unlawful interest in a public contract. King was accused of steering city contracts to businesses owned by him and his relatives. King was accused of steering city contracts to businesses owned by him and his relatives and a codefendant, former councilmember Ernest Smith, was convicted of five charges. The judge scheduled sentencing for June 9. After intense public backlash, the Cleveland Clinic reversed course this week on a plan to begin requiring copays up front before doctors' appointments or other nonemergency treatment. The new policy was set to begin next week. The doctor will still see you, even if you don't fork over the copay, and the hospital will arrange a no interest payment plan. That's a relief to critics who said the pay-first policy would disproportionately impact lower income patients and cause people to put off medical care. We will talk about the jury's verdict and the Clinic's decision to begin this week's “Sound of Ideas Reporters Roundtable.”
Are you tired of chronic inflammation, joint pain, or constant fatigue despite changing your diet or taking medications?In this eye-opening video, Dr. Anshul Gupta — a former Cleveland Clinic functional medicine expert — reveals a simple yet powerful water recipe that helps reduce inflammation naturally.Learn -- How water affects your body's pH and inflammation- The science behind alkaline water and its health benefits- 2 powerful recipes — one short-term detox and one long-term support- Research-backed ingredients like baking soda, potassium bicarbonate, cucumber, lemon, and Himalayan salt- The right way and time to drink this water for maximum benefitBuy Inflamma-Pro -https://functionalwellbeingshop.com/collections/inflammation/products/inflamma-pro?variant=45279703335193Buy Anti- Inflammtory Bundle -https://functionalwellbeingshop.com/collections/bundles/products/anti-inflammtory-bundleConsult Dr. Anshul Gupta from anywhere in the world for personalized, root-cause solutions to your thyroid and health concerns." link below for booking consultation.Work With Me -https://www.anshulguptamd.com/work-with-me/Don't forget to like, subscribe, and hit the notification bell for more health tips and treatments from Dr. Anshul Gupta.Take The Thyroid Quiz & Evaluate Your Thyroid Health -https://www.anshulguptamd.com/thyroid-quiz/To Buy Good Quality Supplements Goto -https://functionalwellbeingshop.com/To Buy Good Quality Supplements Goto (For India) -https://www.drguptafunctionalcenter.com/shop/Free Gift 3-day Mito-Thyroid Diet Meal Plan) -https://reversinghashimotobook.com/3-day-meal-plan0:00 – Intro1:24 – How Inflammation Affects Your Body's pH2:02 – Alkaline Water: Fad or Fact?2:38 – Why RO Water Might Be Hurting You3:32 – Research Studies on Alkaline Water5:03 – Not All Alkaline Waters Are Equal5:45 – Intense (Short-Term) Alkaline Water Recipe6:37 – How & When to Drink It7:25 – Long-Term Alkaline Water Recipe9:22 – Final Thoughts & WarningsFor personalized thyroid treatment plans and expert guidance, reach out to Dr. Anshul Gupta.Our approach focuses on holistic and sustainable methods to manage thyroid health and enhance energy levels.https://functionalwellbeingshop.com/collections/allConnect With Me -Instagram - https://www.instagram.com/anshulguptamd/Twitter - https://www.twitter.com/anshulguptamdFacebook - https://www.facebook.com/drguptafunctPinterest - https://www.pinterest.com/anshulguptamdTo Buy Good Quality Supplements Goto -https://functionalwellbeingshop.com/Work With Me -https://www.anshulguptamd.com/work-with-me/Take The Thyroid Quiz & Evaluate Your Thyroid Health -https://www.anshulguptamd.com/thyroid-quiz/About Dr.Anshul Gupta MD -Dr. Anshul Gupta Md Is a Board-certified Family Medicine Physician, With Advanced Certification In Functional Medicine, Peptide Therapy, And Also Fellowship training in Integrative Medicine. He Has Worked At The Prestigious Cleveland Clinic Department Of Functional Medicine As Staff Physician Alongside Dr. Mark Hyman. He Believes In Empowering His Patients To Take Control Of Their Health And Partners With Them In Their Healing Journey.He Now Specializes As A Thyroid Functional Medicine Doctor, And Help People Reverse Their Unresolved Symptoms Of Thyroid Dysfunction.
In this week's motivational podcast, NBA superstar Kevin Love reflects on a very public panic attack during a game. Love was sure he was having a cardiac event, and went to the Cleveland Clinic. It was then he admitted that he needed help. Love details what had kept him from getting help in the past, including gender stereotypes and stigma surrounding mental health. Plus, Love opens up on how therapy helped him become unapologetically himself and how his grandmother's sudden death impacted him.
It might sound like a cliche, but men in the U.S. are not going to the doctor, and their physical and mental health is suffering. A recent survey from the Cleveland Clinic found that nearly 40% of Gen Z men didn’t have a primary care doctor. And the life expectancy gap between men and women is widening. That’s according to the Journal of the American Medical Association. Today, we talk with physicians about the state of men’s health and what they’re learning from their male patients. GUESTS: Dr. David Inyangetor: Primary Care Physician at Trinity Health George Gogas: LCSW at Charter Oak Therapeutic Services, LLC Dr. Harrell Jordan: Executive Dean of Chamberlain University Support the show: http://wnpr.org/donateSee omnystudio.com/listener for privacy information.
Something we all agree on: No quotas for speeding tickets Learn more about your ad choices. Visit megaphone.fm/adchoices
Aaron Gerds, MD, MS, Cleveland Clinic, Cleveland, OH Recorded on May 13, 2025 Aaron Gerds, MD, MS Associate Professor of Medicine Cleveland Clinic Lerner College of Medicine Case Western Reserve University School of Medicine Medical Director Case Comprehensive Cancer Center Clinical Research Office Cleveland, OH In this episode, Dr. Aaron Gerds from the Cleveland Clinic explores the intricacies of Myeloproliferative Neoplasms (MPNs), from diagnosis and monitoring to treatment goals and the latest therapeutic advances. Dr. Gerds discusses emerging therapies, the significance of clinical trials, strategies for managing side effects and long-term effects, and valuable resources for healthcare professionals, patients, and families. Tune in today for expert insights on MPNs! This episode is supported by GSK plc and Karyopharm Therapeutics.
At the beginning of May, the National Institutes of Health, part of the Department of Health and Human Services, announced a plan to develop a universal vaccine platform. Think: a single shot for flu or COVID-19 that would last years, maybe a lifetime. The plan—called Generation Gold Standard—has a reported budget of $500 million, and a tight deadline. But will it work? And where does the science on this actually stand? In this live broadcast, Hosts Flora Lichtman and Ira Flatow talk with epidemiologist Michael Osterholm and vaccine researcher Ted Ross.Guests: Michael Osterholm is Director of the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota in Minneapolis, Minnesota.Dr. Ted Ross is the global director of vaccine research at the Cleveland Clinic's Florida Research and Innovation Center in Port St. Lucie, Florida. Transcript will be available after the show airs on sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.
We're expected to find out this week exactly how Missouri Governor Mike Kehoe wants to address facilities for the Chiefs and Royals by holding a special session in Jeff City. It feels now or never for the Show Me state as even Mayor Q is publicly saying he won't be a beggar to keep the teams. What on earth is the WNBA doing allowing it's players to be publicly racist? Are they trying to kill the only good thing that's ever happened when Caitlin Clark showed up? Tom Brady did a ride along at the Indy 500 and got boo'd by the fans. His social media post afterwards wins the internet. Pete Hegseth gave one of the greatest Memorial Day speeches ever. Rahm Emmanuel has plans to move the Dem Party to the middle and Scott Pelley ruins graduation with the most self serving speech ever. The Cleveland Clinic drops a bombshell on the really, really bad flu shot and we remember Duck Dynasty's Phil Roberston.
This week's episode dives into COPD treatment. When considering inhaler devices, what is the best strategy for COPD patients? Host Amy Attaway, MD, MS, associate director of the COPD Center at Cleveland Clinic welcomes Anthony Anzueto, MD, professor of medicine at the University of Texas Health Science Center and chief of the pulmonary section for the South Texas Veterans Healthcare System in San Antonio.Support for this podcast is brought to you by Viatris and Theravance BioPharma.
In this special one-year anniversary episode of The Atrium, host Dr. Alice Copperwheat speaks with Dr. Michael Mack, medical director of cardiothoracic surgery at Baylor Scott and White Health System and chairman of the Baylor Plano Research Center in Texas, about the future of valve surgery. Chapters 00:00 Introductions 01:18 Dr. Mack Background 03:41 Becoming a CT Surgeon 07:53 Path to Academic Surgery 10:19 Unconventional Thinking 11:30 TAVR vs SAVR 21:54 Surgical Replacement Future 25:59 Minimally Invasive Preference 27:27 Long-Term Data Impact 30:58 Aortic Valve Research Status 35:35 Mitral Clip vs Repair, Tricuspid 41:40 Mitral Robotic 44:38 Artificial Intelligence 48:43 Specializing Your Career 52:53 Three Career Tips They discuss transcatheter aortic valve replacement (TAVR), surgical aortic valve replacement (SAVR), MitraClips, the mitral valve, and the tricuspid valve. They also explore future research, the role of artificial intelligence (AI) and Dr. Mack provides advice for trainees. The Atrium is a monthly podcast presenting clinical and career-focused topics for residents and early career professionals across all cardiothoracic surgery subspecialties. Watch for next month's episode on radial artery harvesting with Dr. Faisal Bakaeen of the Cleveland Clinic. Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.
In this episode of Medicine Grand Rounders, we're join by hematologist extrodinaire Dr. Dana Angelini, who goes over the do's and don'ts of anticoagulation for the Internal Medicine Physician. Moderated by: Seysha Mehta, MS3
This episode, recorded live at the Becker's Hospital Review 15th Annual Meeting, features Kate Neal, IT Director, Access Innovations and CRM at Cleveland Clinic, and Charlie Lougheed, CEO & Founder of Axuall. They discuss the critical role of accurate provider data in patient access, care coordination, and workforce optimization—and how automation and analytics are transforming outdated, manual processes across healthcare.This episode is sponsored by Axuall.
(May 20, 2025 - Hour Two)10:35pm - With the time I have left, I will run through some general housekeeping items that need cleaned up, give you a BBQ recap from a few weeks ago and give you the results of my very first executive physical that I took yesterday at the Cleveland Clinic. Interesting results to say the least...The BBQ Central Show SponsorsPrimo GrillsPitts & Spitts BBQ Pits - Use "bbqcentral" at checkout for a free spice pack.Big Poppa Smokers – Use promo code “REMPE15” for 15% off your entire purchase!FireboardPit Barrel CookerMicallef Cigars – Premium Hand Rolled Cigars
As estrogen drops, our midlife brains go through a lot of changes. The activity in our dopamine network declines, which can leave us going from highly motivated to “meh.” We can experience bigger cortisol spikes and have elevated levels of the stress hormone longer. We can end up feeling constantly stressed out and in a doom spiral we can't quite escape. And it doesn't exactly help that many of us are also firmly entrenched in the most demanding period of our lives. This week's guest, cognitive neuroscientist Therese Huston, PhD, is coming to the rescue with a host of simple–and quick–ways to boost our dopamine, keep cortisol in check, and help our midlife brains be their best.Therese Huston, PhD, is a cognitive neuroscientist at Seattle University and the author of four books. She's always asking, “How can we remove the pesky obstacles that get in the way of smart people?” Her latest book, Sharp: 14 Simple Ways to Improve Your Life with Brain Science, offers science-backed actionable strategies, many of which take 5 minutes or less, to help you make the most of the brain you've got. Therese received her MS and PhD in cognitive psychology from Carnegie Mellon University. She completed a prestigious post-doc in cognitive neuroscience at the Center for the Neural Basis of Cognition and earned a degree in Organizational Leadership at Oxford University. She frequently gives talks and runs workshops for organizations like Microsoft, Amazon, Morgan Stanley, Strava, and the Cleveland Clinic. She also loves a good 5K, especially when the rain takes a pause in her hometown of Seattle. You can learn more about her, her work, and her books at www.theresehuston.com.Resources: The Healthy Minds Program app hereSubscribe to the Feisty 40+ newsletter: https://feistymedia.ac-page.com/feisty-40-sign-up-page Follow Us on Instagram:Feisty Menopause: @feistymenopause Hit Play Not Pause Facebook Group: https://www.facebook.com/groups/807943973376099 Support our Partners:Midi Health: You Deserve to Feel Great. Book your virtual visit today at https://www.joinmidi.com/ Nutrisense: Go to nutrisense.io/hitplay and use code: HITPLAY to get 30% off Previnex: Get 15% off your first order with code HITPLAY at https://www.previnex.com/ Paradis Sport: Use code: FEISTY20 for 20% off any single item at https://paradissport.com/This podcast uses the following third-party services for analysis: Spotify Ad Analytics - https://www.spotify.com/us/legal/ad-analytics-privacy-policy/Podcorn - https://podcorn.com/privacyPodscribe - https://podscribe.com/privacy
Meet pediatric otolaryngologist Alisa Timashpolsky, who joins the podcast to discuss the latest in otology, rhinology and multidisciplinary care for complex ENT conditions found in children.
Figuring out if your multiple sclerosis is changing from the relapsing remitting to the secondary progressive stage can be murky. Signs of progression are discussed like slower walking and worsening memory. The underlying reasons for progression are revealed including nervous system injury, remyelination failure, chronic inflammation and aging. Practical ways to improve progressive symptoms are shared. Successful trials for disease-modifying therapy for secondary progressive multiple sclerosis (SPMS) are highlighted. Tolebrutinib, under expedited review by the FDA, has been shown to slow down progression in SPMS patients by targeting cells in the central nervous system causing chronic inflammation. Introducing our new co-host Jamie Holloman MD from The MS Center for Innovations in Care! Dr. Holloman completed in neurology residency at Washington University, followed by a 3-year fellowship at the Cleveland Clinic. He interviews: Christopher Laganke MD, Founder of the Joanne P. LaGanke MS Center, Cullman, Alabama Barry Singer MD, Director of The MS Center for Innovations in Care, Missouri Baptist Medical Center, St. Louis
In this episode, Dr. Howard Chen from the Cleveland Clinic joins us to discuss his experience participating in the NSA Codebreaker Challenge and how it connects to cybersecurity in medical imaging. Dr. Chen explains the structure of the challenge, shares lessons learned, and reflects on how problem-solving skills developed in cybersecurity can apply to radiology and informatics. We also talk about: • His role on the SIIM Security Subcommittee • Ongoing efforts to raise cybersecurity awareness in imaging • Balancing professional responsibilities with personal life • The value of hands-on learning for imaging informatics professionals This episode offers a practical look at how cybersecurity concepts are becoming increasingly relevant in radiology.
Last week, the National Multiple Sclerosis Society and the European Committee for Treatment and Research in Multiple Sclerosis convened a meeting in Dublin, Ireland, to dive deeper into what a new framework for describing MS might look like. There's still a tremendous amount of work to be done here. But, considering that whatever language is eventually adopted will affect every person living with MS, I want to keep you fully informed on this important work. So I'm devoting this entire episode of the podcast to sharing conversations I had with three of the attendees at the meeting in Dublin. First, you'll hear from Dr. Bruce Bebo, the National MS Society's Executive Vice President of Research. Then, you'll hear from Dr. Daniel Ontaneda, a neurologist specializing in MS at the Cleveland Clinic, and, finally, you'll hear from Kathy Smith, who's lived with MS for the past 20 years. As you listen to these conversations, I think you'll hear three slightly different perspectives, but you'll also hear some of the broad concepts and ideas around which there was a high level of agreement at our meeting. We have a lot to talk about! Are you ready for RealTalk MS??! This Week: A meeting to discuss moving to a biologically based description of MS :22 Dr. Bruce Bebo discusses how a new framework for describing MS could impact MS research and people living with MS 3:45 Dr. Daniel Ontaneda describes some of the shortcomings of the current MS course descriptors and discusses how a new framework for describing MS could impact people living with MS 17:34 Kathy Smith explains how current MS course descriptors fail to fully capture her experience as someone living with MS, and explains how new course descriptors could benefit people living with MS 26:24 What's next in the work to develop new course descriptors for MS 35:20 Share this episode 35:44 Have you downloaded the free RealTalk MS app? 36:03 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/403 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com RealTalk MS Episode 279: A New Framework for Researching, Diagnosing, and Treating MS with Professor Tanja Kuhlmann https://realtalkms.com/279 RealTalk MS Episode 280: How the Proposed Framework for Diagnosing and Treating MS Will Affect You with Dr. Tim Coetzee https://realtalkms.com/280 Join the RealTalk MS Facebook Group https://facebook.com/groups/realtalkms Download the RealTalk MS App for iOS Devices https://itunes.apple.com/us/app/realtalk-ms/id1436917200 Download the RealTalk MS App for Android Deviceshttps://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 403 Guests: Dr. Bruce Bebo, Dr. Daniel Ontaneda, Kathy Smith Privacy Policy
Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, "Refining TSC Care: Phenotyping, Clustering, and Clinical Impact," Ajay Gupta, MD, director of the Tuberous Sclerosis Program at Cleveland Clinic, discusses recently published research that used unsupervised clustering to group over 900 patients with tuberous sclerosis complex (TSC) into four clinically meaningful phenotypic clusters. He outlines the distinct traits of each cluster—ranging from tumor risk to cognitive impairment—and explains how variant-specific genetic data helped reinforce these categories. Gupta, who also serves as a professor of neurology at the Cleveland Clinic Lerner School of Medicine, also explores the clinical value of these findings for surveillance planning, early intervention, and future therapeutic trials. He emphasizes that while overlap between clusters exists, this approach lays essential groundwork for precision care and more targeted research in TSC. Looking for more epilpesy discussion? Check out the NeurologyLive® Epilepsy clinical focus page. Episode Breakdown: 1:00 – Study goals and the shift from genotype-to-phenotype toward phenotype-to-genotype mapping 2:40– Overview of the 4 main phenotypic clusters identified in the TSC population 8:05 – Genetic domain associations and their impact on clinical monitoring and treatment 11:50 – Neurology News Minute 14:45 – Understanding overlap between clusters and avoiding overprediction in clinical settings 17:00 – Implications for future surveillance strategies and precision candidate selection in TSC trials The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: FDA AdComm Plans to Review Investigational Cell Therapy Deramiocel for DMD Cardiomyopathy Gene Therapy AAV-GAD Gains Regenerative Medicine Advanced Therapy Designation as Potential Parkinson Treatment Microbiome-Targeting Therapy MaaT033 Continues to Show Promise in Final Phase 1 Readout Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.
From the moment I met Annie Meyer, Co-founder & CEO of Untoxicated, I could tell she was building something special. In this episode, we dive deep into her journey with Untoxicated, a mission-driven skincare brand formulated for people with sensitive skin and built around science, empathy, and real impact. Annie opens up about the personal skin struggles that led her to co-found the brand, how she partnered with an allergist from the Cleveland Clinic, and what it means to create skincare that's not just clean but truly allergen-free. We also discuss entrepreneurship, product-market fit, and what it takes to build a brand that prioritizes people over profit. Annie's insights on distribution, innovation, and bootstrapping are gold for any founder trying to break into the crowded CPG space. Here are some key moments from the episode: * Why “less is more” when formulating products for real skin sensitivities * How saying “no” to retailers helped them stay focused on long-term scale * The power of DTC and Amazon to build trust before entering retail * The decision to price products accessibly, even when investors pushed back * Why partnering with a doctor sets a new standard for skin health Join me, Ramon Vela, in listening to the full episode and get a behind-the-scenes look at what it takes to launch a truly purpose-driven brand in beauty. For more on Untoxicated, visit: https://www.untoxicated.com/ If you enjoyed this episode, please leave The Story of a Brand Show a rating and review. Plus, don't forget to follow us on Apple and Spotify. Your support helps us bring you more content like this! * Today's Sponsors: Compass Rose Ventures - Advisor for CPG Brands: https://compassroseventures.com/contact/ Compass Rose Ventures can help your CPG brand increase customer lifetime value, expand into the US market, create an omnipresent omnichannel footprint, optimize customer journeys, build brand communities, and more. Visit the link above to learn more. Workspace6 - Private Community for 7, 8, 9-figure Brands: https://www.workspace6.io/ Workspace6 is a private community where over 950 seven, eight, and nine-figure brand operators trade insights, solve problems, and shortcut growth. It's the anti-fluff operator's room, and today, you can join the community for $1 for your first 30 days!
This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to outcomesrocket.com A proactive approach to innovation, cross-industry learning, and open knowledge sharing is fundamental to achieving supply chain excellence in healthcare. In this episode, Steve Downey, Chief Supply Chain and Support Services Officer at Cleveland Clinic, shares how his team earned recognition in the Gartner Healthcare Supply Chain Top 25 by fostering a culture of continuous innovation and learning from other industries. He discusses leveraging digital transformation through a standardized tech stack across the system, enabling tools like AI for contract analysis and RPA for product conversions. Steve emphasizes the importance of people and collaboration, highlighting a "team of teams" culture that balances global standards with local empowerment and clinically-driven decisions. He also underscores the strategic role of supply chain in navigating financial pressures and enhancing patient outcomes, encouraging leaders to embrace this moment of opportunity. Tune in and learn how strategic leadership and advanced technologies are reshaping healthcare supply chains! Resources: Connect with and follow Steve Downey on LinkedIn. Follow the Cleveland Clinic on LinkedIn and explore their website.
Can myocardial bridges be more than just incidental findings in cardiac diagnostics? Join us as we unravel this complex topic with Dr. Khaled Ziada from the Cleveland Clinic. You'll gain a deep understanding of how myocardial bridges, often dismissed as non-significant, can impact blood flow, especially when factors like endothelial dysfunction and coronary spasms are involved. Listen in to discover the pivotal role of provocative testing in determining when surgical intervention is truly necessary.We discuss the complex techniques utilized in identifying and evaluating myocardial bridges. From CT scans to angiograms and intravascular ultrasounds, Dr. Ziada walks us through the tools that help pinpoint these bridges with a degree of precision. He also elaborates on the use of dobutamine provocation to assess arterial compression and simulate stress conditions, which can reveal underlying ischemic issues. This comprehensive diagnostic approach is crucial for tailoring surgical and medical treatment strategies to the unique needs of each patient.Finally, we explore the often-underestimated challenges of treating endothelial dysfunction and microvascular disease post-surgery. Dr. Ziada emphasizes the importance of personalized medical therapies and lifestyle interventions in managing these conditions effectively. We also get a glimpse of the exceptional care model at Cleveland Clinic, where patients receive tailored support, whether through virtual or in-person consultations. Collaboration is vital between patients and physicians to enhance quality of life and stability in managing these intricate cardiac conditions and I found Dr. Ziada to have wonderful sense of concern for the well-being of those he works with.You can learn more about the Cleveland clinic HERE.You can email Dr. Ziada directly at ziadaK@ccf.orgChapters(00:00) Myocardial Bridges and Surgery Considerations(06:36) Identification and Evaluation of Myocardial Bridges(16:35) Endothelial Dysfunction and Medical Treatment(28:33) Microvascular Dysfunction and Treatment Options(35:02) Microvascular Dysfunction and Patient Care
The June 2025 podcast explores Patient education related to Nutrition Support and interviews Dr. Gail Cresci, Professor of Medicine in the Cleveland Clinic Lerner College of Medicine of the Case Western Reserve University, and Staff in the Departments of Gastroenterology, Hepatology and Nutrition and Inflammation & Immunity at the Cleveland Clinic in Cleveland, OH. Dr. Cresci discusses the components of enteral nutrition and how these ingredients impact the gut microbiome. She presents the findings of her paper titled, “Understanding How Foods and Enteral Feedings Influence the Gut Microbiome” which reviews over 10,000 papers including both in vitro and in vivo studies to provide a great overview of the field. Business Corporate by Alex Menco | alexmenco.net Music promoted by www.free-stock-music.com Creative Commons Attribution 3.0 Unported License creativecommons.org/licenses/by/3.0/deed.en_US June 2025
Send us a textThe leap from neurology residency to attending brings a critical decision - fellowship training or direct practice? In this compelling episode, Harvard neurologists Dr. Galina Gheihman and Dr. Denis Balaban share their contrasting post-residency paths, offering a roadmap for trainees wrestling with their next career steps.This conversation offers honest, practical guidance for navigating the post-residency landscape. Whether you're considering fellowship, direct practice, academic medicine, or industry roles, you'll gain valuable perspective on aligning your next steps with your true professional passions.• Transitioning from resident to attending involves complex role adjustments, especially when supervising former colleagues• Establishing clinical independence requires navigating new responsibilities in outpatient care and deciding when to manage vs. when to refer• Early career physicians lose the built-in cohort of training years precisely when facing critical career decisions• Building support networks through regular check-ins with division chairs and connecting with fellow educators becomes essential• Medical education lacks structured preparation for the business aspects of medicine including salary negotiation and career advancement• Embracing uncertainty and having honest conversations with patients about complex cases is integral to neurology practice• The most fulfilling aspects of attending life include the teaching-clinical intersection and helping patients navigate fear and uncertaintySupport the showHosts:Dr. Nupur Goel is a second-year neurology resident at Mass General Brigham in Boston, MA. Follow Dr. Nupur Goel on Twitter @mdgoels Dr. Blake Buletko is a vascular neurologist and program director of the Adult Neurology Residency Program at the Cleveland Clinic in Cleveland, OH. Follow Dr. Blake Buletko on Twitter @blakebuletko Follow the Neurophilia Podcast on Twitter and Instagram @NeurophiliaPod
Host Dr. Cherie Erkmen speaks with Dr. Tomislav Mihaljevic, cardiothoracic surgeon and CEO & President of the Cleveland Clinic, about his remarkable path—from early life in Croatia to surgical training in Zurich and Boston—a journey that reflects the international growth of the Cleveland Clinic itself. Now at the helm of one of the world's most prestigious healthcare systems, Dr. Mihaljevic shares how his global experiences continue to shape his vision for delivering exceptional care worldwide.
We got the gang together (minus John, who is on mission). Today, we are talking about diverticulitis with super expert Scott Steele. Scott walks Jason, Patrick, and Kevin through the nuances of modern-day management of diverticulitis. We cover laparoscopic lavage, review decision making for surgical resection after drainage, and discuss the evolving role of antibiotics in uncomplicated cases. Surgical techniques, including resection boundaries and the consideration of diverting ostomies in emergent situations, are also reviewed. DOMINATE THE COLON! Hosts Scott Steele, MD: @ScottRSteeleMD Scott is the Rupert B. Turnbull MD Endowed Chair in Colorectal Surgery and Chairman of Colorectal Surgery at Cleveland Clinic in Cleveland, OH. A graduate of the United States Military Academy at West Point, he was an active duty Army officer for over 20 years, serving as the Chief of Colorectal Surgery at Madigan Army Medical Center. He also received his MBA from Case Western University Weatherhead School of Business and Management. Patrick Georgoff, MD: @georgoff Patrick Georgoff is an Acute Care Surgeon at Duke University. He went to medical school at the University of Pennsylvania, completed General Surgery residency and Surgical Critical Care fellowship at the University of Michigan, and a Trauma Surgery fellowship at the University of Texas in Houston. His clinical practice includes the full spectrum of Acute Care Surgery in addition to elective hernia surgery. Patrick is the Associate Program of the General Surgery Residency and associate Trauma Medical Director at Duke. Kevin Kniery, MD: @Kniery_Bird Kevin is a vascular surgeon at Brooke Army Medical Center. He completed his undergraduate degree at the United States Military Academy in West Point, medical school at Tulane University, general surgery residency at Madigan Army Medical Center, and vascular fellowship at Cornell and Columbia. Jason Bingham, MD: @BinghamMd Jason is a general and bariatric surgeon at Madigan Army Medical Center. He also serves as the Director of Research and Associate Program Director for the general surgery residency program. He received his undergraduate degree from New York University and medical degree at the Uniformed Services University of Health Sciences. He is a medical officer in the US Army with several combat deployments under his belt. Jason's research efforts focus on the management of hemorrhagic shock, trauma induced coagulopathy, and ischemia-reperfusion injury. Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more. If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen
In this episode, Scott Becker shares eight timely healthcare updates, including Medicaid challenges in Texas, CRNA policy shifts in West Virginia, Cleveland Clinic's innovation milestones, and more.
© 2020-2025 Ivy Podcast Discovery LLC
